- Article
Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma
- Patrick Schöffski,
- Vincente Guillem,
- Margarita Garcia,
- Fernando Rivera,
- Josep Tabernero,
- Martin Cullell,
- Jose Antonio Lopez-Martin,
- Patricia Pollard,
- Herlinde Dumez and
- Luis Paz-Ares
- + 1 author
This randomized phase II study evaluated two schedules of the marine compound Plitidepsin with or without co-administration of L-carnitine in patients with renal cell carcinoma. Patients had adequate performance status and organ function.The primary...

